Skip to main content
RLYB logo

Rallybio Corporation

RLYBNASDAQHealthcareBiotechnology

$16.64Today:- (-)1Y +2904.15%

As of Oct 15, 2026 close

Market cap
$96.48M
P/E (TTM)
2.12
Forward P/E
-
Dividend yield
-
52-week range
$0.52$17.57
Volume (live)
-
Avg. volume (3M)
8.25K

Rallybio (RLYB) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Rallybio used $29.81M of cash in operating activities. Free cash flow was −$29.81M.

Rallybio Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rallybio Corporation (RLYB) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-8.98-57.78-74.56-66.65-47.01-26.45-17.56
Depreciation & Amortization0.090.130.150.170.110.060.03
Deferred Income Tax0.000.000.000.000.000.000.10
Stock Based Compensation5.317.9910.929.503.650.700.19
Change in Working Capital-4.19-0.264.28-0.94-3.782.122.07
Change in Accounts Payable-0.15-0.70-0.100.49-0.980.720.73
Change in Other Working Capital-0.570.444.38-4.65-2.801.401.34
Other Operating Activities-0.570.63-1.050.641.511.520.14
Net Cash from Operating Activities-29.81-49.28-60.27-57.28-45.53-22.04-15.03
Investing Activities
Capital Expenditures0.000.00-0.01-0.05-0.33-0.14-0.19
Acquisitions-1.50-2.00-2.25-0.30-2.00-1.940.00
Purchases of Investments-17.70-48.93-110.66-201.32-2.00-1.940.00
Sales/Maturities of Investments46.4784.43138.3389.502.001.940.00
Other Investing Activities18.500.002.25-0.300.000.000.00
Net Cash from Investing Activities47.2733.4927.66-112.17-2.33-2.07-0.19
Financing Activities
Common Stock Issued0.025.410.1451.7786.20145.2131.60
Other Financing Activities0.00-0.210.00-0.69-3.23-0.32-0.03
Net Cash from Financing Activities0.025.200.1451.0882.97144.8931.57
Summary
Net Change in Cash17.47-10.59-32.46-118.3835.10120.7816.35
Cash at Beginning of Period13.9024.4956.96175.33140.2319.463.11
Cash at End of Period31.3713.9024.4956.96175.33140.2319.46
Free Cash Flow-29.81-49.28-60.28-57.34-45.87-22.18-15.21

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Rallybio Cash Flow

What is Rallybio's free cash flow?

Rallybio had negative free cash flow of $29.81M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Rallybio pay dividends or buy back shares?

Rallybio's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition